Furthermore, the repressing effect of sh-NR2F1-AS1 on ECAR, glucose consumption, lactate generation, glutamine consumption, and ATP production of NSCLC cells was abrogated via miR-363-3p inhibitor (Figure 5g–l). The gene discussed is NR2F1; the disease is non-small cell lung carcinoma.